Qpex Biopharma, Inc.   Report issue

For profit Phase 1
Founded: San Diego CA United States (2018)
Status: Acquired by Shionogi (2023)

Organization Overview

First Clinical Trial
2019
NCT03939429
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Qpex Biopharma, Inc.

Active Ingredients

Drugs in Phase 1 Trials (6)

ceftibuten (cedax) (2 trials)

qpx2014 (2 trials)

qpx2015 (1 trial)

qpx7728 (2 trials)

qpx7831 (3 trials)

qpx9003 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 7
  • # of Trial APIs: 6